PAR-2(1-6) (human)
CAS No. 202933-49-1
PAR-2(1-6) (human)( ——— )
Catalog No. M41525 CAS No. 202933-49-1
PAR-2 (1-6) (human) (SLIGKV), a peptide ligand, is a PAR-2 agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 131 | In Stock |
|
| 10MG | 200 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePAR-2(1-6) (human)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPAR-2 (1-6) (human) (SLIGKV), a peptide ligand, is a PAR-2 agonist.
-
DescriptionPAR-2 (1-6) (human) (SLIGKV), a peptide ligand, is a PAR-2 agonist.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number202933-49-1
-
Formula Weight615.78
-
Molecular FormulaC28H53N7O8
-
Purity>98% (HPLC)
-
SolubilityDMSO : 25 mg/mL (40.60 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Belinda Liu, et al. The PAR2 signal peptide prevents premature receptor cleavage and activation. PLoS One. 2020 Feb 20;15(2):e0222685.?
molnova catalog
related products
-
P7C3-OMe
P7C3-OMe, a pro-neurogenic agent, has therapeutic benefits in neurodegenerative diseases. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer.
-
BDS I
Potent and reversible Kv3.4 potassium channel blocker (IC50 = 47 nM); also attenuates inactivation of sodium currents by acting on Nav1.7 and Nav1.3 channels. Enhances TTX-sensitive sodium currents in rat small dorsal root ganglion neurons. Neuroprotective.
-
[Leu8,D-Trp22,Tyr25]...
[Leu8,D-Trp22,Tyr25] Somatostatin-28 is the analog of Somatostatin-28. Somatostatin-28 is a intestinal peptide containing somatostatin in its C-terminal portion.
Cart
sales@molnova.com